Danlin Yang
4Patents
1h-index
22Co-inventors
40Inventor score
Filing activity: May 18, 2017 → Mar 23, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11028169B2 | Antibody molecules for cancer treatment | Chemistry; Metallurgy | 1 | Active |
| US12180278B2 | Antibody targeting CD22 and CD79B | Chemistry; Metallurgy | 0 | Active |
| US12103977B2 | Trispecific antibody targeting CD79b, CD20, and CD3 | Chemistry; Metallurgy | 0 | Active |
| US11795219B2 | Antibody molecules for cancer treatment | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.